Search Results | MSF Science Portal

Journal Article

|

Commentary

Rao VB, Baker H, Coldiron M, Garone D, Rieux C, et al.

2025-05-01 • Lancet Global Health

Journal Article

|

Research

Barks PM, Camacho A, Newport T, Ribeiro F, Ahuka-Mundeke S, et al.

2025-03-25 • Lancet Global Health

Journal Article

|

Commentary

Godard A, Phalkey R, Shepherd S, Rossi S, Tessema MT, et al.

2025-02-03 • Lancet Global Health

Journal Article

|

Research

Sweeney S, Laurence YV, Berry C, Singh MP, Dodd M, et al.

2025-02-01 • Lancet Global Health

BACKGROUND

New 6-month rifampicin-resistant tuberculosis treatment regimens containing bedaquiline, pretomanid, and linezolid (BPaL) with or without moxifloxaci...

Journal Article

|

Letter

Flores A, Falci DR

2025-01-01 • Lancet Global Health

Journal Article

|

Letter

Lee JSF, Sued O, Ribeiro I, Jarvis JN, Burry J

2025-01-01 • Lancet Global Health

Journal Article

|

Research

Nesbitt RC, Azman AS, Asilaza VK, Edwards JK, Gitahi P, et al.

2024-11-01 • Lancet Global Health

Journal Article

|

Review

Lee JSF, Cohen RM, Khan RA, Burry J, Casas EC, et al.

2024-09-01 • Lancet Global Health

Journal Article

|

Short Report

Broger T, Marx FM, Theron G, Marais BJ, Nicol MP, et al.

2024-07-01 • Lancet Global Health

Journal Article

|

Commentary

Naim C, Pokorny J, Uyen A, Shortall C, Farra A, et al.

2024-07-01 • Lancet Global Health

Journal Article

|

Commentary

Juan-Giner A, Hombach J

2024-03-01 • Lancet Global Health

Journal Article

|

Research

Bonnet MMB, Vasiliu A, Tchounga BK, Cuer B, Fielding K, et al.

2023-10-30 • Lancet Global Health

BACKGROUND
Globally, the uptake of tuberculosis-preventive treatment (TPT) among children with household tuberculosis contact remains low, partly due to the necessity of bringing chi...

Journal Article

|

Research

Mafirakureva N, Tchounga BK, Mukherjee S, Youngui BT, Ssekyanzi B, et al.

2023-10-30 • Lancet Global Health

BACKGROUND
WHO recommends household contact management (HCM) including contact screening and tuberculosis-preventive treatment (TPT) for eligible children. The CONTACT trial found in...

Journal Article

|

Research

Broger T, Koeppel L, Huerga H, Miller P, Gupta-Wright A, et al.

2023-06-01 • Lancet Global Health

BACKGROUND
Sputum is the most widely used sample to diagnose active tuberculosis, but many people living with HIV are unable to produce sputum. Urine, in contrast, is readily availab...

Journal Article

|

Letter

Huerga H, Gupta-Wright A, Muyindike WR, Hewison CCH, Casenghi M, et al.

2023-04-01 • Lancet Global Health

Journal Article

|

Research

Abouyannis M, Esmail H, Hamaluba M, Ngama M, Mwangudzah H, et al.

2023-02-01 • Lancet Global Health

Snakebite clinical trials have often used heterogeneous outcome measures and there is an urgent need for standardisation. A globally representative group of key stakeholders came togethe...

Journal Article

|

Research

Huerga H, Bastard M, Lubega AV, Akinyi M, Antabak NT, et al.

2023-01-01 • Lancet Global Health

BACKGROUND
Development of rapid biomarker-based tests that can diagnose tuberculosis using non-sputum samples is a priority for tuberculosis control. We aimed to compare the diagnost...

Journal Blog

|

Perspective

Fotheringham C

2017-11-10 • Lancet Global Health

Journal Article

|

Review

Park JS, Grais RF, Taljaard M, Nakimuli-Mpungu E, Jehan F, et al.

2021-05-01 • Lancet Global Health

This paper shows the scale of global health research and the context in which we frame the subsequent papers in the Series. In this Series paper, we provide a historical perspective on c...

Journal Article

|

Letter

Dorlo TPC, Balasegaram M

2014-08-19 • Lancet Global Health

Science Portal

Evolving crises and unprecedented need: Research on health in humanitarian settings must not be overlooked

Evaluation of a decentralised model of care on case isolation and patient outcomes during the 2018–20 Ebola outbreak in the Democratic Republic of the Congo: a retrospective observational study

Medical oxygen: a necessity or a luxury in humanitarian settings?

24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation

Improving access to liposomal amphotericin B worldwide

Improving access to liposomal amphotericin B worldwide – Authors’ reply

Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South Sudan

Paving the way for affordable and equitable liposomal amphotericin B access worldwide

Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research

The role of humanitarian actors in global governance for AMR

The life-long protective immunity of yellow fever vaccination: time to review?

Effectiveness of a community-based approach for the investigation and management of children with household tuberculosis contact in Cameroon and Uganda: a cluster-randomised trial

Cost-effectiveness of community-based household tuberculosis contact management for children in Cameroon and Uganda: a modelling analysis of a cluster-randomised trial

Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data

Lots of considerations when evaluating the FujiLAM assay – Author's reply

A global core outcome measurement set for snakebite clinical trials

Novel FujiLAM assay to detect tuberculosis in HIV-positive ambulatory patients in four African countries: a diagnostic accuracy study

Cervical cancer deaths: a blind spot in global women's health

Urgently seeking efficiency and sustainability of clinical trials in global health

Different Liposomal Amphotericin B Formulations for Visceral Leishmaniasis